Okogen, Developer of Pink Eye Treatment, Raises $10 million

Share on facebook
Share on twitter
Share on linkedin
Share on google

The San Diego Union Tribune covers Okogen’s receival of $10 million in Series A funding to further invest in treatments for viral conjunctivitis.

Read more here.